MIM
EFTRW

Monashee Investment Management’s eFFECTOR Therapeutics, Inc. Warrant EFTRW Stock Holding History

Monashee Investment Management’s Portfolio EFTRW Stock Details EFTRW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-133,332
Closed -$213K – 139
2021
Q3 		$213K Hold
133,332
– – 0.04% 147
2021
Q2 		$133K Hold
133,332
– – 0.02% 299
2021
Q1 		$81K Buy
+133,332
New +$129K 0.01% 305

Other funds holding EFTRW

AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
ICMH
Integrity Capital Management (HK) Central, Hong Kong $64K AUM
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return

Monashee Investment Management's EFTRW Position: Q4 2021 in Review

Monashee Investment Management sold out of eFFECTOR Therapeutics, Inc. Warrant (EFTRW) in Q4 2021, closing a stake of 133,332 shares — an estimated $213K sold.

Monashee Investment Management first reported a position in EFTRW in Q1 2021 and held it in 3 quarters. The position peaked at $213K in Q3 2021. 17 funds tracked by Wall St. Rank hold EFTRW as of Q4 2021.

  • Monashee Investment Management reported no remaining eFFECTOR Therapeutics, Inc. Warrant position as of Q4 2021 after selling out during the quarter.
  • Monashee Investment Management sold 133,332 eFFECTOR Therapeutics, Inc. Warrant shares in Q4 2021, an estimated $213K.
  • Monashee Investment Management first reported a position in eFFECTOR Therapeutics, Inc. Warrant in Q1 2021 and held it in 3 quarters.
  • Monashee Investment Management's eFFECTOR Therapeutics, Inc. Warrant position peaked at $213K in Q3 2021.
  • 17 funds tracked by Wall St. Rank held eFFECTOR Therapeutics, Inc. Warrant as of Q4 2021.

Based on Monashee Investment Management's 13F filing for Q4 2021, filed 7 Feb 2022.